Group of epothilone B glucoside compounds and enzymatic preparation and application thereof

Li Yuezhong,Zhang Peng,Wu Changsheng,Tang Yajie
2020-01-01
Abstract:The invention discloses a group of epothilone B glucoside compounds. The group of epothilone B glucoside compounds comprises epothilone B 7-O-beta-D glucoside, epothilone B 7-O-beta-D-glucosyl-(1 3)-beta-D glucoside, epothilone B 7-O-beta-D-glucosyl-(1 2)-beta-D glucoside and epothilone B 7-O-beta-D-glucosyl-(1 2)-beta-D-glucosyl-beta-(1 4)-beta-D glucoside. The compounds are obtained by a mediated glycosylation reaction of epothilone B and UDP-O-beta-D-glucose with an I62A mutant protein of glycosyltransferase BsGT-1. The invention also discloses application of the epothilone B glucoside compounds in preparation of medicines for preventing and treating liver cancer. Experiments prove that when the concentration of the compound epothilone B 7-O-beta-D glucoside is 9.84 [mu]M, the compound epothilone B 7-O-beta-D glucoside has a semi-inhibition effect on human hepatoma carcinoma cells HepG2; and the toxicity of the compound epothilone B 7-O-beta-D glucoside to normal liver cells HL7702 is reduced by 9430 times compared with the toxicity of the epothilone B. Thus, the application value of epothilone in antitumor activity is expected to be increased, and socialbenefits and economic values are improved.
What problem does this paper attempt to address?